LPATH, INC. SUBSCRIPTION AGREEMENTSubscription Agreement • February 10th, 2012 • Lpath, Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 10th, 2012 Company Industry JurisdictionThe undersigned (the “Investor”) hereby confirms its agreement with Lpath, Inc., a Nevada corporation (the “Company”), as follows:
LPATH, INC. SUBSCRIPTION AGREEMENTSubscription Agreement • December 23rd, 2011 • Lpath, Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledDecember 23rd, 2011 Company Industry JurisdictionThe undersigned (the “Investor”) hereby confirms its agreement with Lpath, Inc., a Nevada corporation (the “Company”), as follows:
LPATH, INC. SUBSCRIPTION AGREEMENTSubscription Agreement • December 7th, 2011 • Lpath, Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledDecember 7th, 2011 Company Industry JurisdictionThe undersigned (the “Investor”) hereby confirms its agreement with Lpath, Inc., a Nevada corporation (the “Company”), as follows:
SUBSCRIPTION AGREEMENTSubscription Agreement • June 29th, 2011 • NovaBay Pharmaceuticals, Inc. • Pharmaceutical preparations • California
Contract Type FiledJune 29th, 2011 Company Industry JurisdictionThe undersigned (the “Investor”) hereby confirms its agreement with NovaBay Pharmaceuticals, Inc., a Delaware corporation (the “Company”), as follows:
NEW GENERATION BIOFUELS HOLDINGS, INC. SUBSCRIPTION AGREEMENTSubscription Agreement • December 11th, 2009 • New Generation Biofuels Holdings, Inc • Industrial organic chemicals • New York
Contract Type FiledDecember 11th, 2009 Company Industry JurisdictionThe undersigned (the “Investor”) hereby confirms its agreement with New Generation Biofuels Holdings, Inc., a Florida corporation (the “Company”), as follows:
NOVABAY PHARMACEUTICALS, INC. SUBSCRIPTION AGREEMENTSubscription Agreement • August 21st, 2009 • NovaBay Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 21st, 2009 Company Industry JurisdictionThe undersigned (the “Investor”) hereby confirms its agreement with NovaBay Pharmaceuticals, Inc., a California corporation (the “Company”), as follows:
SUBSCRIPTION AGREEMENTSubscription Agreement • May 19th, 2009 • Cytokinetics Inc • Pharmaceutical preparations • New York
Contract Type FiledMay 19th, 2009 Company Industry JurisdictionThe undersigned (the “Investor”) hereby confirms its agreement with Cytokinetics, Incorporated, a Delaware corporation (the “Company”), as follows:
SUBSCRIPTION AGREEMENTSubscription Agreement • May 8th, 2009 • Discovery Laboratories Inc /De/ • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 8th, 2009 Company Industry JurisdictionThe undersigned (the “Investor”) hereby confirms its agreement with Discovery Laboratories, Inc., a Delaware corporation (the “Company”), as follows:
SUBSCRIPTION AGREEMENTSubscription Agreement • July 16th, 2008 • Jazz Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledJuly 16th, 2008 Company Industry JurisdictionPlease confirm that the foregoing correctly sets forth the agreement between us by signing in the space provided below for that purpose.
SUBSCRIPTION AGREEMENTSubscription Agreement • August 15th, 2007 • Lev Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 15th, 2007 Company Industry JurisdictionPlease confirm that the foregoing correctly sets forth the agreement between us by signing in the space provided below for that purpose.